Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hanwha Systems (272210) – Results of Extraordinary General Meeting of Shareholders / 2024-10-22 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-07-30 Disclosures
  • [Disclosure] HPSP (403870) – Resolution on Calling of General Meeting of Shareholders / 2026-02-12 Semiconductors
  • [Disclosure] Celltrion (068270) – Decision on Acquisition of Treasury Shares / 2025-05-20 Disclosures
  • [Disclosure] Hana Micron (067310) – Investor Relations (IR) Meeting / 2026-05-20 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – Preliminary Earnings Results (Consolidated) / 2024-08-08 Disclosures
  • [Disclosure] Daeduck Electronics (353200) – Decision on Cash/In-Kind Dividend / 2024-02-28 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Investor Relations (IR) Announcement (Informational Disclosure) / 2026-04-13 Disclosures

[Disclosure] HPSP (403870) – Decision on Stock Retirement / 2026-02-12

Posted on February 12, 2026August 1, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

HPSP has decided to retire 1,699,120 treasury common shares (valued at approximately KRW 73.4B) on March 13, 2026, to enhance corporate value.

📊 [Key Disclosure Details & Financial Figures]

  1. Details and Scale of Stock Retirement
  • Type and Number of Shares to be Retired: 1,699,120 common shares
  • Par Value per Share: KRW 500
  • Estimated Retirement Amount: KRW 73,401,984,000 (KRW 73.4B)
    • Calculated based on the closing price of KRW 43,200 on February 11, 2026 (the day prior to the board resolution date); the actual retirement amount may vary.
  1. Retirement Method and Schedule
  • Purpose of Retirement: Enhancement of corporate value
  • Acquisition Method of Shares to be Retired: Previously acquired treasury stock
  • Scheduled Retirement Date: March 13, 2026
    • Subject to change during consultations with relevant authorities
  • Expected Acquisition Period / Entrusted Brokerage: Not applicable (utilizing previously acquired treasury stock)
  1. Changes in Total Outstanding Shares and Capital Stock
  • Total Outstanding Shares Before Retirement: 83,999,120 common shares
  • Total Outstanding Shares After Retirement: 82,300,000 common shares (expected)
  • Impact on Capital Stock: Retired within the scope of distributable profits pursuant to the proviso of Article 343, Paragraph 1 of the Commercial Act; while the total number of issued shares will decrease, there will be no reduction in capital stock.
  1. Board Resolution Details
  • Board Resolution Date: February 12, 2026
  • Attendance of Outside Directors: 3 present / 0 absent
  • Attendance of Audit Committee: Present
  • Fair Trade Commission Reporting Requirement: Not applicable
  • Other: This disclosure serves in lieu of a disclosure on the disposal of treasury stock.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Completion of Stock Retirement and Reduction in Total Outstanding Shares

This stock retirement decision is a shareholder return policy aimed at increasing value per share by eliminating previously acquired treasury shares without reducing capital stock. Verifying whether the retirement of 1,699,120 shares is executed as scheduled and the total outstanding shares are successfully reduced to 82,300,000 shares is important for confirming the actual realization of corporate value enhancement. The execution progress can be verified in future official filings, such as the ‘Total Number of Shares’ section in periodic reports (Annual, Quarterly, or Half-Yearly Reports) or subsequent official disclosures regarding listing modification.

📢 Disclaimer & Source Notice

Source: This content was newly generated and structured based on officially submitted data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial responsibilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] HPSP (403870) – Decision on Cash and In-Kind Dividend / 2026-02-12
Next Post: [Disclosure] Celltrion (068270) – Resolution on Convocation of General Shareholders’ Meeting / 2026-02-12

Related Posts

  • [Disclosure] ALTEOGEN (196170) – Results of Annual General Meeting of Shareholders / 2024-03-26 Bio & Healthcare
  • [Disclosure] Celltrion (068270) – Approval of US FDA Marketing Authorization for Avtozma (CT-P47, Actemra Biosimilar) / 2025-01-31 Disclosures
  • [Disclosure] Celltrion (068270) – Approval of IND Amendment for CT-P55 (Cosentyx Biosimilar) U.S. Phase 3 Clinical Trial / 2026-05-12 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – Filing of Legal Proceedings / 2026-05-22 Disclosures
  • [Disclosure] Celltrion (068270) – Provisional Separate Financial Results / 2025-02-25 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – Record Date or Closure of Shareholders’ Register Notice / 2026-03-27 Disclosures
  • [Disclosure] Hana Micron (067310) – New Facility Investment / 2024-06-10 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · ADR Listing · Valuation Re-rating / 2026-03-23 RESEARCH
  • [Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract (Voluntary Disclosure) / 2025-06-10 Disclosures
  • [Disclosure] PSK Holdings (031980) – Submission of Audit Report / 2024-03-21 Semiconductors
  • [Disclosure] SK Hynix (000660 / SKHY) – Occurrence of Serious Industrial Accident / 2026-06-26 Semiconductors
  • [Disclosure] Hanwha Systems (272210) – Resolution to Convene Annual General Meeting of Shareholders / 2024-02-23 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Audit Report Submission / 2026-02-25 Disclosures
  • [Disclosure] Hanwha Systems (272210) – (Correction) Resolution on Convening of General Meeting of Shareholders / 2025-10-30 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme